| KARYOPHARM THERAPEUTICS |
| USA |
| Gesundheit |
| US48576U2050 / A40YLC |
| 25K0 (Frankfurt) / KPTI (NASDAQ) |
| FRA:25K0, ETR:25K0, 25K0:GR, NASDAQ:KPTI |
| - |
| https://www.karyopharm.co.. |
|
Karyopharm Therapeutics Inc. is a commercial-stage biopharmaceutical company specializing in the discovery, development, and commercialization of innovative cancer therapies. The company focuses on nuclear export inhibition, having developed small-mo..
>Volltext.. |
| 134.91 Mio. EUR |
| 255.44 Mio. EUR |
| 131.13 Mio. EUR |
| -72.87 Mio. EUR |
| -169.18 Mio. EUR |
| -12.9 EUR |
| 200.34 Mio. EUR |
| 78.83 Mio. EUR |
| -51.29 Mio. EUR |
| 0.77 |
| -0.44% |
| -192% |
| - |
| - |
| - |
| KARYOPHARM |
| 31.07.26 |
|